Ten years of TRALI mitigation: measuring our progress
BACKGROUND Transfusion‐related acute lung injury (TRALI) is a leading cause of transfusion‐associated mortality for which multiple mitigation strategies have been implemented over the past decade. However, product‐specific TRALI rates have not been reported longitudinally and may help refine additio...
Gespeichert in:
Veröffentlicht in: | Transfusion (Philadelphia, Pa.) Pa.), 2019-08, Vol.59 (8), p.2567-2574 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND
Transfusion‐related acute lung injury (TRALI) is a leading cause of transfusion‐associated mortality for which multiple mitigation strategies have been implemented over the past decade. However, product‐specific TRALI rates have not been reported longitudinally and may help refine additional mitigation strategies.
STUDY DESIGN AND METHODS
This retrospective multicenter study included analysis of TRALI rates from 2007 through 2017. Numerators included definite or probable TRALI reports from five blood centers serving nine states in the United States. Denominators were components distributed from participating centers. Rates were calculated as per 100,000 components distributed (p |
---|---|
ISSN: | 0041-1132 1537-2995 |
DOI: | 10.1111/trf.15387 |